BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10092326)

  • 1. Is antibody testing for inflammatory bowel disease clinically useful?
    Panaccione R; Sandborn WJ
    Gastroenterology; 1999 Apr; 116(4):1001-2; discussion 1002-3. PubMed ID: 10092326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relevance of serologic studies in inflammatory bowel diseases].
    Papp M; Altorjay I; Lakatos PL
    Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies: new biological tools for diagnosis of inflammatory bowel disease].
    Bourreille A; Doubremelle M; Colombel JF
    Rev Med Interne; 2003 Mar; 24(3):147-50. PubMed ID: 12657435
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive and negative predictive values: use of inflammatory bowel disease serologic markers.
    Austin GL; Shaheen NJ; Sandler RS
    Am J Gastroenterol; 2006 Mar; 101(3):413-6. PubMed ID: 16542272
    [No Abstract]   [Full Text] [Related]  

  • 5. Serological diagnosis of inflammatory bowel disease.
    Rutgeerts P; Vermeire S
    Lancet; 2000 Dec 23-30; 356(9248):2117-8. PubMed ID: 11191535
    [No Abstract]   [Full Text] [Related]  

  • 6. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
    Buckland MS; Mylonaki M; Rampton D; Longhurst HJ
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1328-30. PubMed ID: 16275949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in clinical laboratory tests for inflammatory bowel disease.
    Nakamura RM; Matsutani M; Barry M
    Clin Chim Acta; 2003 Sep; 335(1-2):9-20. PubMed ID: 12927679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antineutrophil cytoplasmic antibodies (ANCA) in chronic inflammatory intestinal disease].
    García Herola A; Nos Mateu P; Ponce García J
    Gastroenterol Hepatol; 2000 Jan; 23(1):16-23. PubMed ID: 10726379
    [No Abstract]   [Full Text] [Related]  

  • 9. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease.
    Iborra M; Beltrán B; Nos P
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):641-56. PubMed ID: 27633593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of serological and genetic markers in inflammatory bowel disease; strength and weakness of the studies.
    Peña AS
    Rev Esp Enferm Dig; 2003 Nov; 95(11):752-4, 749-51. PubMed ID: 14640872
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical indications of the use of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in the evaluation of inflammatory bowel disease at an Academic Medical Center.
    Gupta A; Derbes C; Sellin J
    Inflamm Bowel Dis; 2005 Oct; 11(10):898-902. PubMed ID: 16189419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of perinuclear antineutrophil cytoplasmic antibodies (pANCA) in inflammatory bowel disease].
    López Serrano P; Santander C; Fernández Rodríguez C
    Med Clin (Barc); 2004 Jun; 123(3):119. PubMed ID: 15225480
    [No Abstract]   [Full Text] [Related]  

  • 13. Exploring life before IBD.
    De Vroey B; Gower-Rousseau C; Colombel JF
    Gut; 2013 May; 62(5):662-3. PubMed ID: 22936675
    [No Abstract]   [Full Text] [Related]  

  • 14. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
    Hartman C; Eliakim R; Shamir R
    Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
    [No Abstract]   [Full Text] [Related]  

  • 15. Serologic markers in inflammatory bowel disease (IBD).
    Nakamura RM; Barry M
    MLO Med Lab Obs; 2001 Nov; 33(11):8-15; quiz 16-9. PubMed ID: 11721286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antineutrophil cytoplasmatic antibodies and their diagnostic significance as serum markers].
    Terjung B; Spengler U; Sauerbruch T
    Dtsch Med Wochenschr; 1999 Nov; 124(44):1314-20. PubMed ID: 10596294
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic tools in inflammatory bowel diseases].
    Bouhnik Y
    Rev Prat; 2005 May; 55(9):977-83. PubMed ID: 16052968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].
    Desreumaux P; Bourreille A; Colombel JF
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S81-6. PubMed ID: 12704300
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of perinuclear antineutrophil cytoplasmic antibodies and antinuclear antibodies in the diagnosis of canine inflammatory bowel disease.
    Mancho C; Sainz A; García-Sancho M; Villaescusa A; Tesouro MA; Rodríguez-Franco F
    J Vet Diagn Invest; 2010 Jul; 22(4):553-8. PubMed ID: 20622225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.